Who owns the REPORTINGPHARM trademark?

The REPORTINGPHARM trademark is owned by Health Strategy, LLC.

What class is the REPORTINGPHARM trademark registered in?

The REPORTINGPHARM trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for REPORTINGPHARM?

The USPTO serial number for REPORTINGPHARM is 97884473.

What is the registration number for REPORTINGPHARM?

REPORTINGPHARM is registered under USPTO registration number 7756507.

Sealvo

Home Search: REPORTINGPHARMREPORTINGPHARM #97884473

Back

Updated Oct 29, 2026·40 searches this week

View on USPTO TSDR Find similar marks

REP

USPTO Trademark Record

REGISTERED

REPORTINGPHARM

SN 97884473·Reg 7756507·Filed Apr 12, 2023

Owner Health Strategy, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REPORTINGPHARM (Serial No. 97884473), Registration No. 7756507, is a registered US trademark filed on Apr 12, 2023 by Health Strategy, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: April 08, 2031

Mark Intelligence

REPORTINGPHARM (Reg. #7756507) is a registered US trademark that has been protecting its owner, Health Strategy, LLC, since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Apr 12, 2023

SERIAL

97884473

REG#

7756507

REGISTERED

Apr 08, 2025

Filing Information

StatusREGISTERED

Filing DateApr 12, 2023

Serial Number97884473

Registration No.7756507

Registration DateApr 08, 2025

Status DateApr 08, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 30, 2024

First use in commerce: May 30, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

REGISTERED-SUPPLEMENTAL REGISTER

Apr 08, 2025

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 08, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

USE AMENDMENT ACCEPTED

Mar 13, 2025

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Mar 13, 2025

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 13, 2025

LAW OFFICE PUBLICATION REVIEW COMPLETED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Dec 27, 2024

TEAS REQUEST FOR RECONSIDERATION RECEIVED

TEAS AMENDMENT OF USE RECEIVED

Dec 27, 2024

TEAS AMENDMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 27, 2024

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Dec 27, 2024

AMENDMENT TO USE PROCESSING COMPLETE

FINAL REFUSAL WRITTEN

Oct 28, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 28, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 28, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 15, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 15, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Oct 11, 2024

ASSIGNED TO LIE

TEAS PETITION TO REVIVE RECEIVED

Jun 27, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jun 27, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Jun 27, 2024

NOTICE OF REVIVAL - E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 27, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

May 01, 2024

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

May 01, 2024

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

NON-FINAL ACTION WRITTEN

Jan 16, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 16, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 16, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jan 09, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 06, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 15, 2023

NEW APPLICATION ENTERED

Other Marks by Health Strategy, LLC

Additional USPTO filings from the same owner.

REP

REPORTINGPHARM

85755571

Health Strategy, LLC

REGISTERED

HEA

HEALTH STRATEGY RX MARKETPLACE PROCESS

97037306

Health Strategy, LLC

PENDING

RXP

RX PRICE GUARD

98926457

Health Strategy, LLC

PENDING

RXM

RX MARKETPLACE

90470855

Health Strategy, LLC

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

REP

REPORTINGPHARM

85755571

Health Strategy, LLC

REGISTERED

Other Marks by Annette P. Heller

Additional USPTO filings handled by the same attorney of record.

CRA

CRANE GROUP

98691206

REGISTERED

CRA

CRANE GROUP

98784734

REGISTERED

HYP

HYPERDIP

88555536

REGISTERED

98912608

REGISTERED

REPORTINGPHARM

Run a conflict check

Other Marks by Health Strategy, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Annette P. Heller

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company